CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MAMS4CL project seeks to improve treatment options for cutaneous leishmaniasis by evaluating multiple novel therapeutic interventions through a randomized trial. It aims to identify safer and more effective treatments to enhance patient access and outcomes in Ethiopia and beyond.
Cutaneous leishmaniasis (CL) is a neglected tropical disease affecting more than one million people globally each year.
In Ethiopia alone more than 40,000 people are thought to be affected annually.
Infection results in stigmatising, visible, chronic, scarring skin lesions which cause permanent morbidity and significantly affect mental health, household financial stability and life chances.There is a major need for new therapeutics for CL.
The current first line therapy is intramuscular sodium…
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, ANTWERPEN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
ARMAUER HANSEN RESEARCH INSTITUTE
Ethiopia, Addis Ababa
Type: Research institute
Activity type: Research Organisations
SME: No
South Africa, Stellenbosch
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Ethiopia, Arba Minch
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
